Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistanttuberculosis management models in Eswatini. We compared the cost-consequence of a home-based multidrug-resistanttuberculosis (MDR-TB) model of care, based on task-shifting of directly observed therapy (DOT) and MDR-TB injection administration to lay health workers, to a routine clinic-based strategy within
Determinants of sputum culture conversion time in multidrug-resistanttuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study. The treatment response of multi-drug resistance tuberculosis (MDR-Tuberculosis) patients is mainly dictated by the sputum culture conversion. An earlier culture conversion is a remarkable indicator
Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistanttuberculosis in Peru. Whole Genome Sequencing (WGS) is a promising tool in the global fight against tuberculosis (TB). The aim of this study was to evaluate the use of WGS in routine conditions for detection of drug resistance markers and transmission clusters in a multidrug
Levofloxacin for the Prevention of Multidrug-ResistantTuberculosis in Vietnam. Prevention of drug-resistant tuberculosis is a global health priority. However, trials evaluating the effectiveness of treating infection among contacts of persons with drug-resistant tuberculosis are lacking. We conducted a double-blind, randomized, controlled trial comparing 6 months of daily levofloxacin (weight
Patch Test-Positive Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Due to Cycloserine in Multidrug-ResistantTuberculosis: A Case Report with a Review of the Literature. Antitubercular treatment (ATT) is associated with multiple cutaneous adverse drug reactions. Second-line ATT is also associated with numerous adverse reactions; however, cutaneous reactions are under-reported . Oral drug provocation (ODP) in multidrug-resistanttuberculosis is challenging because of the paucity of time and the risk of developing secondary drug resistance in the case of interrupted medication. In this paper, we report a case of drug reaction with eosinophilia and systemic symptoms caused by cycloserine in an 18-year-old girl, which was confirmed with ODP and a patch test.
Evaluation of High-Dose Isoniazid in Multidrug-ResistantTuberculosis Treatment. High-dose isoniazid is recommended to treat multidrug-resistanttuberculosis (MDR TB). Among 958 MDR TB isolates identified in France during 2008-2022, 93.1% exhibited high-level isoniazid resistance, and molecular testing showed limited diagnostic accuracy in predicting resistance. Clinicians should reconsider using
Evaluation of a modified short all oral treatment regimen for rifampicin-multidrugresistanttuberculosis in Dominican Republic. This study aims to evaluate the effectiveness, safety, and impact on health-related quality of life (HQoL) of a fully oral shortened regimen for Rifampicin-Resistant/Multidrug-ResistantTuberculosis (RR/MDR-TB) over 9 to 12 months under programmatic conditions
Global burden of multidrug-resistanttuberculosis in children and adolescents. Multidrug-resistanttuberculosis (MDR-TB) has become a major global public health issue, which has worsened over time owing to changes in disease-related trends. This study aimed to determine global trends in MDR-TB among children and adolescents for strategic health planning. A secondary analysis was performed on MDR
Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-ResistantTuberculosis Setting: A Retrospective Cohort Study. Evidence shows that isoniazid preventive therapy (IPT) reduces tuberculosis (TB) incidence among people with human immunodeficiency virus (HIV) with additive benefit beyond
The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistanttuberculosis in Sudan. This study used Targeted Maximum Likelihood Estimation (TMLE) as a double robust method to estimate the causal effect of previous tuberculosis treatment history on the occurrence of multidrug-resistanttuberculosis (MDR-TB). TMLE
Predictors of multidrug-resistanttuberculosis in a teaching hospital in Ghana: A case-control study. Multidrug-resistantTuberculosis (MDR-TB) remains a global health concern. The disease results in a prolonged treatment and hence, poses a financial burden to affected individuals and their families. The Ghana National TB Control Programme (NTP) has made extensive efforts to control the menace
Addressing patients' unmet needs related to multidrug-resistanttuberculosis (MDR-TB) care: A qualitative research study from Pune city, India. We aimed to identify and describe the unmet needs of patients with multidrug-resistanttuberculosis (MDR-TB). As a part of larger cross-sectional mixed-methods (qualitative and quantitative data) study on pathways to MDR-TB care, here we present
Second-line anti-tuberculosis drug exposure thresholds predictive of adverse events in multidrug-resistanttuberculosis treatment. This study aimed to investigate the association between drug exposure and adverse events (AEs) during the standardized multidrug-resistanttuberculosis (MDR-TB) treatment, as well as to identify predictive drug exposure thresholds. We conducted a prospective
Bedaquiline Resistance after Effective Treatment of Multidrug-ResistantTuberculosis, Namibia. Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk
Transmission of Fluoroquinolones Resistance among Multidrug-ResistantTuberculosis in Shanghai, China: A Retrospective population-based Genomic Epidemiology Study. Fluoroquinolones (FQ) are essential for the treatment of multidrug-resistanttuberculosis (MDR-TB). The FQ resistance (FQ-R) rate in MDR-TB in China and its risk factors remain poorly understood. We conducted a retrospective
Risk factors for diagnosis and treatment delay among patients with multidrug-resistanttuberculosis in Hunan Province, China. Multidrug-resistanttuberculosis (MDR-TB) is a global health threat associated with high morbidity and mortality rates. Diagnosis and treatment delays are associated with poor treatment outcomes in patients with MDR-TB. However, the risk factors associated
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistanttuberculosis in Indonesia. Pharmacokinetic data on high-dose isoniazid for the treatment of rifampicin-/multidrug-resistanttuberculosis (RR/MDR-TB) are limited. We aimed to describe the pharmacokinetics of high-dose isoniazid, estimate exposure target attainment, identify
Relationship between HIV viral suppression and multidrugresistanttuberculosis treatment outcomes. The impact of HIV viral suppression on multidrugresistanttuberculosis (MDR-TB) treatment outcomes among people with HIV (PWH) has not been clearly established. Using secondary data from a cluster-randomized clinical trial among people with MDR-TB in South Africa, we examined the effects of HIV
A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistanttuberculosis in China: study protocol for PROSPECT. The lack of safe, effective, and simple short-course regimens (SCRs) for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment has
Global prevalence and burden of multidrug-resistanttuberculosis from 1990 to 2019. Tuberculosis(TB) remains a pressing public health challenge, with multidrug-resistanttuberculosis (MDR-TB) emerging as a major threat. And healthcare authorities require reliable epidemiological evidence as a crucial reference to address this issue effectively. The aim was to offer a comprehensive